| Christopher H Bozarth, MD | |
|
230 N Midwest Blvd, Midwest City, OK 73110-4321 | |
| (405) 737-8455 | |
| (405) 739-8707 |
| Full Name | Christopher H Bozarth |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 30 Years |
| Location | 230 N Midwest Blvd, Midwest City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811997265 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 19505 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
We know that what happens in the mouth doesn't stay in the mouth - but the oral cavity's connection to the rest of the body goes way beyond chewing, swallowing and digestion.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 7 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
We know that what happens in the mouth doesn't stay in the mouth - but the oral cavity's connection to the rest of the body goes way beyond chewing, swallowing and digestion.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 7 days ago
| Entity Name | Norman Urology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679645055 PECOS PAC ID: 6103888961 Enrollment ID: O20041103000406 |
News Archive
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
We know that what happens in the mouth doesn't stay in the mouth - but the oral cavity's connection to the rest of the body goes way beyond chewing, swallowing and digestion.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 7 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
We know that what happens in the mouth doesn't stay in the mouth - but the oral cavity's connection to the rest of the body goes way beyond chewing, swallowing and digestion.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher H Bozarth, MD 230 N Midwest Blvd, Midwest City, OK 73110-4321 Ph: (405) 737-8455 | Christopher H Bozarth, MD 230 N Midwest Blvd, Midwest City, OK 73110-4321 Ph: (405) 737-8455 |
News Archive
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
We know that what happens in the mouth doesn't stay in the mouth - but the oral cavity's connection to the rest of the body goes way beyond chewing, swallowing and digestion.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 7 days ago
Bart Michael-lane Rowlett, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Radiology Dept., Midwest City, OK 73110 Phone: 405-610-8938 | |
Laura M Young, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Radiology Dept., Midwest City, OK 73110 Phone: 405-610-8398 | |
Jason Pack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Radiology Dept., Midwest City, OK 73110 Phone: 405-610-8398 | |
Alfred C Degner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Radiology Dept., Midwest City, OK 73110 Phone: 405-610-8398 | |
Gregory Campbell, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2825 Parklawn Dr, Radiology Dept., Midwest City, OK 73110 Phone: 405-610-8398 |